Notes on Randomized Trials: Two-Group Design

Trials

The transcript states: 'randomized means we have two groups.'
In a randomized trial, participants are randomly assigned to two groups, typically:
- Treatment group: receives the intervention being tested.
- Control group: receives placebo or standard care.
Random assignment helps balance known and unknown confounders between groups, reducing selection bias and enabling more reliable causal inferences.

Two groups are compared to determine whether the intervention has an effect.
The counterfactual concept: what would have happened to each participant if they had been assigned to the other condition.

Randomization methods include simple randomization, block randomization, stratified randomization.
Blinding can be single-blind or double-blind to minimize performance and assessment bias.
Outcomes are typically designated as primary and secondary.
Analysis approaches often include intention-to-treat and per-protocol analyses.
Sample size calculations and power analyses help ensure the study can detect a meaningful difference.
Ethical considerations include informed consent and clinical equipoise.

Example scenario: evaluate a new drug vs placebo.
Participants are randomly assigned to receive the new drug or placebo.
Outcomes are compared after a defined follow-up period to assess efficacy and safety.

Randomization reduces bias and supports causal conclusions under proper conduct.
Limitations can include imperfect blinding, non-adherence, loss to follow-up, and deviations from the protocol.

Randomized trials involve two groups created by randomization; the goal is to compare outcomes to infer the effect of the intervention.